Collectively, our results demonstrate that inhibition of calpain regulated VSMC phenotypic switch via miR-223/IGF-1R/AMPK signaling axis, supporting the potential application of calpeptin on platelet-associated vascular disease in diabetes. This evidence concerns the gene PRKAB1 and diabetes mellitus.